Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology

Search Medical Condition
Please enter condition
Please choose location from dropdown

Scalp Disorders Clinical Trials

A listing of Scalp Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (14) clinical trials

This study will be conducted to evaluate the therapeutic bioequivalence of a TEST formulation of calcipotriene hydrate and betamethasone dipropionate topical suspension 0.005%/0.064% to the RLD.

Phase

Patient Inclusion Criteria: 18+ years of age Diagnosis of stable plaque psoriasis Mild to moderate on trunk and/or limbs Patient Exclusion Criteria: Current diagnosis of guttate, erythrodermic or pustular psoriasis

Phase

At least 18 years of age Mild to severe psoriasis Only three visits Up to $150 for time and travel

Phase N/A

We are conducting a research study evaluating the safety and effectiveness of an investigational shampoo for scalp psoriasis. Qualified participants will receive study related exams and study medication at no charge. Please contact us today!

Phase N/A

Scalp Psoriasis Research Study This study evaluates an investigational topical medication for Scalp Psoriasis.

Phase N/A

A research study is evaluating an investigational topical medication for actinic keratosis (AK) lesions of the face or scalp. This research study may be an option if you: • Have 4-8 actinic keratosis lesions on the face or scalp • Do not have any atypical or rapidly changing AK lesions ...

Phase N/A

Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases

Timeframe Collection of DNA for discovery cohort until 05/2016 Data analysis until 12/2014 for pyoderma gangrenosum, until 12/2016 for other NMID Report and data presentation early 2015 for PG, 2017 for other NMID

Phase N/A

Shorter Scalp Cooling Time in Paclitaxel

Chemotherapy-induced alopecia (CIA) is one of the most distressing side effects for patients. Scalp cooling can prevent or minimise CIA in approximately half of all patients, depending on many factors, e.g. type and dosage of chemotherapy. High rates of success are seen in patients treated with taxanes, up to 80-90%. ...

Phase N/A